CLOIvsIBDQ
VanEck CLO ETF against iShares iBonds Dec 2025 Term Corporate ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| CLOI | IBDQ | |
|---|---|---|
| Expense ratio | 0.40% | 0.10% |
| Assets | $52.8B | $2.3B |
| Net flow, 1 month | — | — |
| Net flow, 1 year | — | −$478M |
| Return, YTD | -0.0% | — |
| Return, 1 year | -0.2% | +0.1% |
| Avg daily volume | 474K | — |
| Holdings | 19 | 675 |
| Listed | Jun 23, 2022 | Mar 11, 2015 |
| Options market | No | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS